Anne Bruggemans

4PUBLICATIONS
1CO-AUTHORS
Industrial molecular engineering of nucleic acids and proteinsMedical virologyMedical devicesMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 27, 2026
The LEDGIN GS-9822 inhibits HIV-2 infection and enhances HIV-2 latency.

|Jul 19, 2022
BET-Independent Murine Leukemia Virus Integration Is Retargeted In Vivo and Selects Distinct Genomic Elements for Lymphomagenesis.

Ivan Nombela, Martine Michiels, Dominique Van Looveren

|Feb 23, 2021
GS-9822, a preclinical LEDGIN candidate, displays a block-and-lock phenotype in cell culture.

Anne Bruggemans, Gerlinde Vansant, Mini Balakrishnan

|Dec 28, 2018
Insight in HIV Integration Site Selection Provides a Block-and-Lock Strategy for a Functional Cure of HIV Infection.

Zeger Debyser, Gerlinde Vansant, Anne Bruggemans

Pageof 1

Frequent Collaborators

3 joint publications

Zeger Debyser